Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

N. Lawrence; A. Martin; G. Toner; M. Stockler; L. Buizen; D. Thomson; V. Gebski; M. Friedlander; A. Yeung; N. Wong; H. Gurney; M. Rosenthal; N. Singhal; G. Kichenadasse; S. Wong; C. Lewis; P. Vasey; P. Grimison

doi:10.1093/annonc/mdw313

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Annals of Oncology ◽

10.1093/annonc/mdw313 ◽

2016 ◽

Vol 27 (12) ◽

pp. 2302-2303 ◽

Cited By ~ 1

Author(s):

N. Lawrence ◽

A. Martin ◽

G. Toner ◽

M. Stockler ◽

L. Buizen ◽

...

Keyword(s):

Prostate Cancer ◽

New Zealand ◽

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Long Term Outcomes ◽

Multicentre Phase ◽

Cancer Trials

Download Full-text

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Annals of Oncology ◽

10.1093/annonc/mdt369 ◽

2014 ◽

Vol 25 (1) ◽

pp. 143-148 ◽

Cited By ~ 19

Author(s):

P.S. Grimison ◽

M.R. Stockler ◽

M. Chatfield ◽

D.B. Thomson ◽

V. Gebski ◽

...

Keyword(s):

Prostate Cancer ◽

New Zealand ◽

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Multicenter Phase ◽

Cancer Trials

Download Full-text

Faculty Opinions recommendation of Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718219865.793492489 ◽

2014 ◽

Author(s):

Robert Huddart

Keyword(s):

Prostate Cancer ◽

New Zealand ◽

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Multicenter Phase ◽

Cancer Trials

Download Full-text

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

European Journal of Cancer ◽

10.1016/j.ejca.2019.12.028 ◽

2020 ◽

Vol 127 ◽

pp. 139-149

Author(s):

Fay H. Cafferty ◽

Jeff D. White ◽

Jonathan Shamash ◽

Ivo Hennig ◽

Sally P. Stenning ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Long Term Outcomes

Download Full-text

Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

Annals of Oncology ◽

10.1093/annonc/mdy283.124 ◽

2018 ◽

Vol 29 ◽

pp. viii325

Author(s):

R.A. Huddart ◽

F. Cafferty ◽

J. White ◽

J. Shamash ◽

I.M. Hennig ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2016.10.017 ◽

2017 ◽

Vol 122 (1) ◽

pp. 93-98 ◽

Cited By ~ 11

Author(s):

Hester Lieng ◽

Melania Pintilie ◽

Andrew Bayley ◽

Alejandro Berlin ◽

Robert Bristow ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Intensity Modulated Radiotherapy ◽

Localized Prostate Cancer ◽

Long Term Outcomes ◽

Image Guided ◽

Intensity Modulated

Download Full-text

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumors: updated analysis of an Australian multicenter phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e16056 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e16056-e16056

Author(s):

Peter S. Grimison ◽

Martin R. Stockler ◽

Andrew James Martin ◽

Luke Buizen ◽

Nicola Jane Lawrence ◽

...

Keyword(s):

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

Long Term Outcomes ◽

Multicenter Phase

Download Full-text

39: Long-Term Outcomes of a Phase II Trial of Moderate Hypofractionated Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) for Localized Prostate Cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(16)33438-7 ◽

2016 ◽

Vol 120 ◽

pp. S15 ◽

Cited By ~ 1

Author(s):

Hester Lieng ◽

Melania Pintilie ◽

Alejandro Berlin ◽

Andrew Bayley ◽

Robert Bristow ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Intensity Modulated Radiotherapy ◽

Localized Prostate Cancer ◽

Long Term Outcomes ◽

Image Guided ◽

Intensity Modulated

Download Full-text

Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

European Urology Supplements ◽

10.1016/s1569-9056(19)32534-5 ◽

2019 ◽

Vol 18 (4) ◽

pp. 28

Author(s):

R.A. Huddart ◽

F. Cafferty ◽

J.D. White ◽

J. Shamash ◽

I. Hennig ◽

...

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Phase Ii ◽

Poor Prognosis ◽

Phase Ii Trial ◽

Germ Cell Tumours ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

Superior survival after sequential high-dose chemotherapy (HDCT) as compared to single HDCT in patients with relapsed or refractory germ cell tumors (GCT): Six-year long-term follow-up of a prospective, randomized phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4507 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4507-4507 ◽

Cited By ~ 1

Author(s):

A. Lorch ◽

A. Kleinhans ◽

A. Kramar ◽

J. T. Hartmann ◽

C. Bokemeyer ◽

...

Keyword(s):

Germ Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Germ Cell Tumors ◽

High Dose Chemotherapy ◽

High Dose ◽

Randomized Phase Ii ◽

Long Term Follow Up

Download Full-text

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

British Journal of Haematology ◽

10.1111/bjh.13592 ◽

2015 ◽

Vol 171 (3) ◽

pp. 373-377 ◽

Cited By ~ 9

Author(s):

Peter M. Voorhees ◽

Robert Z. Orlowski ◽

Flora Mulkey ◽

Peter Watson ◽

Susan Geyer ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Pegylated Liposomal Doxorubicin ◽

Newly Diagnosed ◽

Long Term Outcomes ◽

Multicentre Phase

Download Full-text